Human IgG antibody Laboratories manufactures the anti-irf9 antibody produced in mouse reagents distributed by Genprice. The Anti-Irf9 Antibody Produced In Mouse reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact mouse Antibody. Other Anti-Irf9 products are available in stock. Specificity: Anti-Irf9 Category: Antibody Group: Produced In
IRF9 Antibody |
NSJ Bioreagents |
0.4 ml |
EUR 322.15 |
Description: IRF9 is a transcription regulatory factor that mediates signaling by type I IFNs (IFN-alpha and IFN-beta). Following type I IFN binding to cell surface receptors, Jak kinases (TYK2 and JAK1) are activated, leading to tyrosine phosphorylation of STAT1 and STAT2. The phosphorylated STATs dimerize, associate with IRF9/ISGF3G to form a complex termed ISGF3 transcription factor, that enters the nucleus. ISGF3 binds to the IFN stimulated response element (ISRE) to activate the transcription of interferon stimulated genes, which drive the cell in an antiviral state. |
IRF9 Conjugated Antibody |
SAB |
100ul |
EUR 476.4 |
anti- IRF9 antibody |
FN Test |
100µg |
EUR 658.5 |
|
Description: Antibody raised against IRF9 |
Produced In information
anti-HSV (II) gB IgG1 (monoclonal) Produced against a HSV (II) infected cells. |
021-A-100ugvial |
Virogen |
100 ug/vial |
EUR 150 |
|
Description: anti-HSV (II) gB IgG1 (monoclonal) Produced against a HSV (II) infected cells. |
anti-HCMV IE pp72 IgG2a (monoclonal) Produced against a HCMV IE concentrate. |
022-A-100ugvial |
Virogen |
100 ug/vial |
EUR 150 |
|
Description: anti-HCMV IE pp72 IgG2a (monoclonal) Produced against a HCMV IE concentrate. |
anti-HCMV IE pp65 IgG1 (monoclonal) Produced against a HCMV infected cells. |
023-A-100ugvial |
Virogen |
100 ug/vial |
EUR 150 |
|
Description: anti-HCMV IE pp65 IgG1 (monoclonal) Produced against a HCMV infected cells. |
anti-HIV-1 p55/17 IgG1 (monoclonal) Produced against a recombinant protein. |
013-A-100ugvial |
Virogen |
100 ug/vial |
EUR 150 |
|
Description: anti-HIV-1 p55/17 IgG1 (monoclonal) Produced against a recombinant protein. |
anti-HSV (I) gD IgG1 (monoclonal) Produced against a HSV (I) viral concentrate |
020-A-100ugvial |
Virogen |
100 ug/vial |
EUR 150 |
|
Description: anti-HSV (I) gD IgG1 (monoclonal) Produced against a HSV (I) viral concentrate |
anti-Dengue NS1 Type 2 IgG1 (monoclonal) Produced against a recombinant protein. |
111-A-100ugvial |
Virogen |
100 ug/vial |
EUR 150 |
Description: anti-Dengue NS1 Type 2 IgG1 (monoclonal) Produced against a recombinant protein. |
anti-Rotavirus p42 IgG2a (monoclonal) Produced against purified bovine rotavirus virus. |
027-A-100ugvial |
Virogen |
100 ug/vial |
EUR 150 |
|
Description: anti-Rotavirus p42 IgG2a (monoclonal) Produced against purified bovine rotavirus virus. |
anti-Rotavirus p42 IgG2a (monoclonal) Produced against purified bovine rotavirus virus. |
276-A-100ugvial |
Virogen |
100 ug/vial |
EUR 150 |
|
Description: anti-Rotavirus p42 IgG2a (monoclonal) Produced against purified bovine rotavirus virus. |
anti-HCV NS4B IgG2b (monoclonal)Produced against recombinant antigen epitope a.a. 1748 to 1754 |
245-A-100ugvial |
Virogen |
100 ug/vial |
EUR 150 |
|
Description: anti-HCV NS4B IgG2b (monoclonal)Produced against recombinant antigen epitope a.a. 1748 to 1754 |
anti-HCV NS4B IgG2b (monoclonal)Produced against recombinant antigen epitope a.a 1713 to 1717 |
247-A-100ugvial |
Virogen |
100 ug/vial |
EUR 150 |
|
Description: anti-HCV NS4B IgG2b (monoclonal)Produced against recombinant antigen epitope a.a 1713 to 1717 |
anti-GSK3 Beta IgG2a (monoclonal). Produced against a recombinant Xenopus laevis protein. |
011-A-100ugvial |
Virogen |
100 ug/vial |
EUR 150 |
|
Description: anti-GSK3 Beta IgG2a (monoclonal). Produced against a recombinant Xenopus laevis protein. |
anti-HCV core IgG1 (monoclonal) Produced against a recombinant, HCV core 00115-V, protein. |
0116-A-100ugvial |
Virogen |
100 ug/vial |
EUR 150 |
|
Description: anti-HCV core IgG1 (monoclonal) Produced against a recombinant, HCV core 00115-V, protein. |
anti-HCV core IgG2a (monoclonal) Produced against a recombinant, HCV core 00115-V, protein. |
0117-A-100ugvial |
Virogen |
100 ug/vial |
EUR 150 |
|
Description: anti-HCV core IgG2a (monoclonal) Produced against a recombinant, HCV core 00115-V, protein. |
Recombinant Mycoplasma Pulmonis (Mp) protein antigens (mammalian cell produced) |
MPUL15-N-10 |
Alpha Diagnostics |
10 ug |
EUR 270 |
anti-HBsAg surface antigen IgG1 (monoclonal) Produced against HBsAg purified from human sera pool. |
032-A-100ugvial |
Virogen |
100 ug/vial |
EUR 150 |
|
Description: anti-HBsAg surface antigen IgG1 (monoclonal) Produced against HBsAg purified from human sera pool. |
anti-HBcAg core IgG2a (monoclonal) Produced against recombinant HBcAg core antigen. Epitope: 70 – 80 a.a. |
033-A-100ugvial |
Virogen |
100 ug/vial |
EUR 150 |
|
Description: anti-HBcAg core IgG2a (monoclonal) Produced against recombinant HBcAg core antigen. Epitope: 70 – 80 a.a. |
anti-HBcAg core IgG2a (monoclonal) Produced against recombinant HBcAg core antigen. Epitope: 1-10 a.a. |
036-A-100ugvial |
Virogen |
100 ug/vial |
EUR 150 |
|
Description: anti-HBcAg core IgG2a (monoclonal) Produced against recombinant HBcAg core antigen. Epitope: 1-10 a.a. |